Sector Update: Health Care Stocks Retreating Late Afternoon
Health care stocks eased in late Wednesday afternoon trading, with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) each decreasing 0.1%. The iShares Biotechnology ETF (IBB
MT NewswiresApr 17 15:53 ET
Sector Update: Health Care
Health care stocks ease in late Wednesday afternoon trading with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) both decreasing 0.1%. The iShares Biotechnology ETF (IBB)
MT NewswiresApr 17 15:32 ET
Connect Biopharma Terminates Agreement on Antiallergic Candidate With Pfizer
Connect Biopharma (CNTB) is terminating its in-license agreement for CBP-174, an antiallergic, with Pfizer (PFE), effective May, to optimize resources and extend its cash runway The company said Tuesd
MT NewswiresApr 17 14:48 ET
Connect Biopharma Is Maintained at Buy by HC Wainwright & Co.
Connect Biopharma Is Maintained at Buy by HC Wainwright & Co.
Dow JonesApr 17 06:50 ET
Express News | HC Wainwright & Co. Maintains Buy on Connect Biopharma Hldgs, Raises Price Target to $8
Moomoo 24/7Apr 17 06:40 ET
Connect Biopharma Hldgs Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 04/17/2024 390.8% HC Wainwright & Co. $7 → $8 Maintains Buy 03/04/2024 329.45% HC Wainwright & Co. → $7 In
BenzingaApr 17 06:37 ET
Analysts Are Bullish on These Healthcare Stocks: BioNTech SE (BNTX), Connect Biopharma Holdings (CNTB)
TipRanksApr 17 06:20 ET
Connect Biopharma Triumphs With Rademikibart Trials
TipRanksApr 16 17:27 ET
Connect Biopharma GAAP EPS of -$2.15 Misses by $1.33
Seeking AlphaApr 16 16:31 ET
Express News | Connect Biopharma Hldgs FY EPS $(1.08) Up From $(2.15) YoY
Moomoo 24/7Apr 16 16:22 ET
Express News | Connect Biopharma Holdings : Cash, Cash Equivalents & Short-Term Investments of $118.7 Mln Expected to Support Planned Operations Into at Least 2026
Moomoo 24/7Apr 16 16:06 ET
Press Release: Connect Biopharma Reports Full Year 2023 Financial Results and Provides Business Update
Connect Biopharma Reports Full Year 2023 Financial Results and Provides Business Update -- Reported two positive readouts for rademikibart, the Company's lead asset, from the Global Phase 2b
Dow JonesApr 16 16:05 ET
Connect Biopharma Reports Full Year 2023 Financial Results and Provides Business Update
Reported two positive readouts for rademikibart, the Company's lead asset, from the Global Phase 2b trial in moderate-to-severe persistent asthma and from the China pivotal trial in moderate-to-severe
Connect Biopharma Apr 16 00:00 ET
Buy Rating Reaffirmed for Connect Biopharma Holdings Amid Promising Clinical Trials and Strategic Partnerships
TipRanksApr 10 02:17 ET
12 Health Care Stocks Moving In Wednesday's After-Market Session
GainersAesthetic Medical Intl (NASDAQ:AIH) shares rose 14.0% to $0.52 during Wednesday's after-market session. The company's market cap stands at $24.9 million. Kineta (NASDAQ:KA) shares rose 8.46% to
BenzingaApr 3 16:31 ET
MMAT, CNTB and HGAS Among Mid-day Movers
Seeking AlphaApr 1 12:57 ET
ADRs End Higher; Connect Biopharma Holdings Climbs 21%
This article was automatically generated by Dow Jones Newswires using technology from Automated Insights. International stocks trading in New York closed higher on Wednesday, as the S&P/BNY Mellon in
Dow JonesMar 27 16:40 ET
Connect Biopharma to Participate in H.C. Wainwright 2nd Annual Autoimmune & Inflammatory Disease Virtual Conference
SAN DIEGO and TAICANG, China, March 19, 2024 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) ("Connect Biopharma" or the "Company"), a global clinical-stage biopharmaceutical c
Connect Biopharma Mar 19 00:00 ET
Express News | Connect Biopharma Holdings Shares Are Trading Higher After HC Wainwright & Co Initiated Coverage on the Stock With a Buy Rating and Announced a $7 Price Target
Moomoo 24/7Mar 4 15:31 ET
SMR, BBAI and PHUN Are Among Pre Market Gainers
Seeking AlphaMar 4 08:34 ET
No Data
No Data